The well-being of patients is our highest priority. We aim to facilitate the development of a regulated cannabis market in Europe to help patients obtain the best possible therapy.
Safety and quality are the most important factors for us. Our cannabis is imported from GMP-certified producers, who adhere to the highest standards. Every step of our supply chain from the cultivation to the distribution is strictly regulated and controlled.
Although the beneficial medical properties of cannabis are increasingly established, developments aimed at leveraging these benefits have been slow in Europe. Cannovum clearly focuses on the European market, pioneering our cannabis revolution and thriving to implement a safe and sustainable industry.
Subscribe to our newsletter to stay updated:
Copyright CANNOVUM AG © 2020
Rheinsberger Str. 76/77